Yaz

Yaz is one of the best-selling oral contraception pills in the U.S. Yaz is a combination birth control pill that contains estrogen and progestin. It is considered a low-dose pill, in that it contains .035 milligrams or less of estrogen. Yaz received FDA approval as an oral contraceptive in March 2006, and as a treatment for the emotional and physical symptoms of premenstrual dysphoric disorder (PMDD) in October 2006. In January 2007, Yaz was approved to treat moderate acne in women who desire an oral contraceptive for birth control.

Yaz contains a synthetic type of progestin called drospirenone. According to the FDA, drospirenone can lead to hyperkalemia, a condition caused by excessive amounts of potassium in the blood, in high risk patients. This condition may result in potentially serious heart and health problems. Women taking YAZ must also be concerned about the drug interactions that could increase potassium, in addition to the drug interactions common to all combination oral contraceptives.

Bayer has downplayed these risks when marketing the drug. In October 2008, the FDA cited two Yaz commercials for deceptive claims. In a warning letter, the FDA faulted Bayer for overstating the benefits of Yaz. The FDA also criticized the ads for containing fast-moving images and background music that might be distracting to viewers. As a part of an agreement with the FDA Bayer began running a new ad campaign in February 2009 to correct information conveyed by the deceptive Yaz commercials.

If you or a loved one has been affected by the serious side effects of Yaz, contact an attorney at Hach & rose today.